CAH
CARDINAL HEALTH INC
NYSE · Healthcare · Medical - Distribution · US
$225.38
−0.42%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- $2.93
- Revenue estimate
- $67.0B
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- $2.91
- EPS estimate
- $2.43
- Revenue actual
- $63.7B
- Revenue estimate
- $65.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 12
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +15.8%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $271
- PT range
- $250 – $280
- Analysts
- 12
11 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | $2.43 | $2.91 | Beat 19.95% | $63.7B |
| Apr 30, 2026 | $2.79 | $3.17 | Beat 13.50% | $60.9B |
| Feb 5, 2026 | $2.34 | $2.63 | Beat 12.49% | $65.4B |
| Oct 30, 2025 | $2.18 | $2.55 | Beat 17.08% | $64.0B |
| Aug 12, 2025 | $2.04 | $2.08 | Beat 1.96% | $60.2B |
| May 1, 2025 | $2.17 | $2.35 | Beat 8.10% | $54.9B |
| Jan 30, 2025 | $1.75 | $1.93 | Beat 10.35% | $55.3B |
| Nov 1, 2024 | $1.63 | $1.88 | Beat 15.20% | $52.3B |
| Aug 14, 2024 | $1.74 | $1.84 | Beat 5.93% | $59.9B |
| May 2, 2024 | $1.96 | $2.08 | Beat 6.23% | $54.9B |
| Feb 1, 2024 | $1.60 | $1.82 | Beat 13.61% | $57.4B |
| Nov 3, 2023 | $1.40 | $1.73 | Beat 23.57% | $54.8B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026